• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面增强激光解吸电离质谱(SELDI)图谱在不同时间和实验室间的可重复性

Reproducibility of SELDI Spectra Across Time and Laboratories.

作者信息

Diao Lixia, Clarke Charlotte H, Coombes Kevin R, Hamilton Stanley R, Roth Jack, Mao Li, Czerniak Bogdan, Baggerly Keith A, Morris Jeffrey S, Fung Eric T, Bast Robert C

机构信息

Departments of Bioinformatics and Computational Biology.

出版信息

Cancer Inform. 2011 Mar 14;10:45-64. doi: 10.4137/CIN.S6438.

DOI:10.4137/CIN.S6438
PMID:21552492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3085423/
Abstract

This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.The reproducibility of mass spectrometry (MS) data collected using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) has been questioned. This investigation was designed to test the reproducibility of SELDI data collected over time by multiple users and instruments. Five laboratories prepared arrays once every week for six weeks. Spectra were collected on separate instruments in the individual laboratories. Additionally, all of the arrays produced each week were rescanned on a single instrument in one laboratory. Lab-to-lab and array-to-array variability in alignment parameters were larger than the variability attributable to running samples during different weeks. The coefficient of variance (CV) in spectrum intensity ranged from 25% at baseline, to 80% in the matrix noise region, to about 50% during the exponential drop from the maximum matrix noise. Before normalization, the median CV of the peak heights was 72% and reduced to about 20% after normalization. Additionally, for the spectra from a common instrument, the CV ranged from 5% at baseline, to 50% in the matrix noise region, to 20% during the drop from the maximum matrix noise. Normalization reduced the variability in peak heights to about 18%. With proper processing methods, SELDI instruments produce spectra containing large numbers of reproducibly located peaks, with consistent heights.

摘要

这是一篇开放获取文章。只要对原始作品进行恰当引用,允许不受限制的非商业用途。使用表面增强激光解吸/电离飞行时间质谱(SELDI-TOF)收集的质谱(MS)数据的可重复性受到了质疑。本研究旨在测试多个用户和仪器随时间收集的SELDI数据的可重复性。五个实验室连续六周每周制备一次芯片。在各个实验室的单独仪器上收集光谱。此外,每周生产的所有芯片都在一个实验室的一台仪器上重新扫描。实验室间和芯片间校准参数的变异性大于不同周运行样品所导致的变异性。光谱强度的变异系数(CV)在基线时为25%,在基质噪声区域为80%,在从最大基质噪声呈指数下降期间约为50%。在归一化之前,峰高的中位数CV为72%,归一化后降至约20%。此外,对于来自同一仪器的光谱,CV在基线时为5%,在基质噪声区域为50%,在从最大基质噪声下降期间为20%。归一化将峰高的变异性降低到约18%。通过适当的处理方法,SELDI仪器产生的光谱包含大量可重复定位的峰,且峰高一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/5494cfaecd85/cin-2011-045f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/5666382005b3/cin-2011-045f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/65be7dd79f5e/cin-2011-045f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/bb9b1e1352b6/cin-2011-045f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/2e86d723b4bb/cin-2011-045f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/5494cfaecd85/cin-2011-045f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/5666382005b3/cin-2011-045f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/65be7dd79f5e/cin-2011-045f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/bb9b1e1352b6/cin-2011-045f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/2e86d723b4bb/cin-2011-045f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e5c/3085423/5494cfaecd85/cin-2011-045f5.jpg

相似文献

1
Reproducibility of SELDI Spectra Across Time and Laboratories.表面增强激光解吸电离质谱(SELDI)图谱在不同时间和实验室间的可重复性
Cancer Inform. 2011 Mar 14;10:45-64. doi: 10.4137/CIN.S6438.
2
Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).表面增强激光解吸/电离(SELDI)飞行时间(TOF)质谱(MS)数据的质量控制与质量评估。
BMC Bioinformatics. 2005 Jul 15;6 Suppl 2(Suppl 2):S5. doi: 10.1186/1471-2105-6-S2-S5.
3
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.表面增强激光解吸/电离飞行时间质谱法评估血清蛋白质谱用于前列腺癌检测:I. 平台重现性评估
Clin Chem. 2005 Jan;51(1):102-12. doi: 10.1373/clinchem.2004.038950.
4
Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform.通过使用未抽取离散小波变换对光谱进行去噪,改进从表面增强激光解吸电离获得的质谱数据的峰检测和定量。
Proteomics. 2005 Nov;5(16):4107-17. doi: 10.1002/pmic.200401261.
5
Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).使用表面增强激光解吸电离飞行时间质谱法(SELDI-TOF-MS)鉴定杜普伊特伦挛缩症中的蛋白质生物标志物。
Clin Invest Med. 2006 Jun;29(3):136-45.
6
Preanalytical and analytical variation of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry of human serum.人血清表面增强激光解吸电离飞行时间质谱的分析前和分析变异
Clin Chem Lab Med. 2006;44(10):1243-52. doi: 10.1515/CCLM.2006.228.
7
Differences in protein profiles of the isolates of Entamoeba histolytica and E. dispar by surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF MS) ProteinChip assays.通过表面增强激光解吸电离飞行时间质谱(SELDI-TOF MS)蛋白质芯片分析,溶组织内阿米巴和迪斯帕内阿米巴分离株蛋白质谱的差异
Parasitol Res. 2007 Dec;102(1):103-10. doi: 10.1007/s00436-007-0736-z. Epub 2007 Sep 11.
8
Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach.基于小波/神经网络的方法进行 SELDI-TOF 质谱的灵敏且特异的峰检测。
PLoS One. 2012;7(11):e48103. doi: 10.1371/journal.pone.0048103. Epub 2012 Nov 12.
9
Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques.使用时间序列分析技术提高血清肽表面增强激光解吸/电离飞行时间质谱记录的灵敏度和分辨率。
Clin Chem. 2005 Jan;51(1):65-74. doi: 10.1373/clinchem.2004.037283. Epub 2004 Nov 18.
10
Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling.用于蛋白质谱分析的反相蛋白质阵列表面增强激光解吸/电离飞行时间质谱(SELDI-TOF MS)的优化与评估。
Clin Chem Lab Med. 2005;43(2):133-40. doi: 10.1515/CCLM.2005.022.

引用本文的文献

1
Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS): A Multiplexed Microarray Platform for Targeted Proteomics.亲和珠辅助质谱法 (Affi-BAMS):一种用于靶向蛋白质组学的多重微阵列平台。
Int J Mol Sci. 2020 Mar 16;21(6):2016. doi: 10.3390/ijms21062016.
2
Sparse Proteomics Analysis - a compressed sensing-based approach for feature selection and classification of high-dimensional proteomics mass spectrometry data.稀疏蛋白质组学分析——一种基于压缩感知的高维蛋白质组学质谱数据特征选择和分类方法。
BMC Bioinformatics. 2017 Mar 9;18(1):160. doi: 10.1186/s12859-017-1565-4.
3
Investigation of serum protein profiles in scrapie infected sheep by means of SELDI-TOF-MS and multivariate data analysis.

本文引用的文献

1
Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease.载脂蛋白 A-I 和血清淀粉样蛋白 A 血浆水平是镰状细胞病患者急性疼痛发作的生物标志物。
Haematologica. 2010 Sep;95(9):1467-72. doi: 10.3324/haematol.2009.018044. Epub 2010 Apr 7.
2
Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.鉴定β2-微球蛋白作为肝硬化患者影像学不可见肝细胞癌早期诊断的候选标志物。
Oncol Rep. 2010 May;23(5):1325-30. doi: 10.3892/or_00000767.
3
Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer.
利用表面增强激光解吸电离飞行时间质谱(SELDI-TOF-MS)和多变量数据分析研究羊瘙痒病感染羊的血清蛋白谱。
BMC Res Notes. 2013 Nov 14;6:466. doi: 10.1186/1756-0500-6-466.
4
A SELDI mass spectrometry study of experimental autoimmune encephalomyelitis: sample preparation, reproducibility, and differential protein expression patterns.SELDI 质谱技术在实验性自身免疫性脑脊髓炎中的应用研究:样本制备、重现性及差异蛋白表达谱。
Proteome Sci. 2013 May 1;11(1):19. doi: 10.1186/1477-5956-11-19.
5
Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets.基于 LC-MS/MS 数据集的比对定量分析对急性白血病进行蛋白质组分类。
J Proteome Res. 2012 Oct 5;11(10):5005-10. doi: 10.1021/pr300567r. Epub 2012 Sep 11.
6
Detection of bladder cancer using proteomic profiling of urine sediments.利用尿沉渣蛋白质组谱检测膀胱癌。
PLoS One. 2012;7(8):e42452. doi: 10.1371/journal.pone.0042452. Epub 2012 Aug 3.
7
A critical assessment of SELDI-TOF-MS for biomarker discovery in serum and tissue of patients with an ovarian mass.对 SELDI-TOF-MS 在卵巢肿块患者血清和组织中生物标志物发现的批判性评估。
Proteome Sci. 2012 Jul 23;10(1):45. doi: 10.1186/1477-5956-10-45.
8
Reproducible cancer biomarker discovery in SELDI-TOF MS using different pre-processing algorithms.基于 SELDI-TOF MS 的不同预处理算法的可重现性癌症生物标志物发现。
PLoS One. 2011;6(10):e26294. doi: 10.1371/journal.pone.0026294. Epub 2011 Oct 14.
鉴定预测非小细胞肺癌化疗耐药的候选分子标志物。
Clin Chem Lab Med. 2010 Jun;48(6):863-7. doi: 10.1515/CCLM.2010.169.
4
Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.通过蛋白质组学分析发现前列腺癌进展的血清蛋白生物标志物。
Cancer Genomics Proteomics. 2010 Mar-Apr;7(2):93-103.
5
Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls.结直肠癌、结直肠良性疾病与健康对照的蛋白质组学模型的差异表达。
Proteome Sci. 2010 Mar 25;8:16. doi: 10.1186/1477-5956-8-16.
6
Detection and identification of potential biomarkers of breast cancer.乳腺癌潜在生物标志物的检测与鉴定。
J Cancer Res Clin Oncol. 2010 Aug;136(8):1243-54. doi: 10.1007/s00432-010-0775-1. Epub 2010 Mar 17.
7
Rapid multiplexed genotyping for hereditary thrombophilia by SELDI-TOF mass spectrometry.
Diagn Mol Pathol. 2010 Mar;19(1):54-61. doi: 10.1097/PDM.0b013e3181a814bf.
8
Increased phosphorylation of vimentin in noninfiltrative meningiomas.非浸润性脑膜瘤中波形蛋白磷酸化增加。
PLoS One. 2010 Feb 16;5(2):e9238. doi: 10.1371/journal.pone.0009238.
9
Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in-gel electrophoresis.通过去除高丰度蛋白质和差异凝胶电泳鉴定卵巢癌血清中的候选生物标志物。
Electrophoresis. 2010 Jan;31(4):599-610. doi: 10.1002/elps.200900441.
10
Tipifarnib plus tamoxifen in tamoxifen-resistant metastatic breast cancer: a negative phase II and screening of potential therapeutic markers by proteomic analysis.替吡法尼联合他莫昔芬治疗他莫昔芬耐药转移性乳腺癌:一项采用蛋白质组学分析筛选潜在治疗标志物的 II 期阴性试验。
Clin Cancer Res. 2010 Feb 15;16(4):1264-71. doi: 10.1158/1078-0432.CCR-09-1192. Epub 2010 Feb 9.